MedTrace Logo

Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer

NCT03154671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 351

Last updated 2022-05-20

No results posted yet for this study

Summary

A multicentre two-group parallel single-blind (outcome assessor) randomized controlled trial (RCT). A cost effectiveness study alongside a clinical trial using a payer and societal perspective to study the cost-effectiveness of geriatric assessment and management compared to usual care will be conducted.

Participants allocated to the control group will receive usual oncology care. Participants allocated to the intervention group will receive a comprehensive geriatric assessment and management in addition to their usual oncology care. The intervention will take 6 months to be completed. Total study follow-up will be 12 months for each participant.

Conditions

Interventions

OTHER

Geriatric assessment and management

Each participant will receive a comprehensive geriatric assessment at baseline. Based on the issues identified, a tailored care plan will be developed with the participant to address the issues identified.

Sponsors & Collaborators

  • University Health Network, Toronto

    collaborator OTHER

  • The Ottawa Hospital

    collaborator OTHER

  • Sir Mortimer B. Davis - Jewish General Hospital

    collaborator OTHER

  • R.S. McLaughlin Durham Cancer Centre, Lakeridge Health

    collaborator UNKNOWN

  • Sunnybrook Health Sciences Centre

    collaborator OTHER

  • Fraser Health

    collaborator OTHER

  • Mount Sinai Hospital, Canada

    collaborator OTHER

  • University of Toronto

    lead OTHER

Principal Investigators

  • Martine Puts, RN PhD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-10
Primary Completion
2021-04-01
Completion
2021-04-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03154671 on ClinicalTrials.gov